3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Completed
1
Approved for marketing
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
CNS
1
Conditions
Brain Neoplasms
364
Glioblastoma
298
Glioma
239
Neuroblastoma
94
Neoplasms
70
Central Nervous System Neoplasms
62
Astrocytoma
61
Meningioma
59
Breast Neoplasms
51
Lung Neoplasms
46
Carcinoma, Non-Small-Cell Lung
45
Melanoma
39
Sarcoma
34
Medulloblastoma
33
Meningeal Carcinomatosis
32
Recurrence
31
Neoplasm Metastasis
28
Diffuse Intrinsic Pontine Glioma
28
Prostatic Neoplasms
27
Pheochromocytoma
27
Paraganglioma
27
Neurofibromatosis 1
26
Pancreatic Neoplasms
24
Ovarian Neoplasms
24
Oligodendroglioma
22
Head and Neck Neoplasms
20
Ependymoma
20
Osteosarcoma
19
Kidney Neoplasms
19
Colorectal Neoplasms
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Pathologic Processes
×
CNS
×
Clear all
NCT07098806
2025-08-01
CA2024-LM-001
Plus Therapeutics
Phase 1
Recruiting
24 enrolled